Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

Číst více

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

Číst více

Thank You!

The End
Číst více

What has been your experience with switching patients from alglucosidase alfa to avalglucosidase alfa?

Current Treatment Landscape & hands on Experience

Číst více

Pompe Care Podcast Series 2

Číst více

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations
Číst více

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience
Číst více

What challenges do clinicians face in monitoring in disease progrission and response to therapy?

Číst více

What challenges do clinicians face in monitoring in disease progrission and response to therapy?

Číst více

Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?

Číst více

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

Číst více

Pompe Care Podcast Series 3

Číst více